AcquisitionOther
CymaBay Therapeutics, Inc. acquired Gilead Sciences, Inc.
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
CymaBay Therapeutics, Inc. -> Gilead Sciences, Inc. · $0.0001
Open source record (SEC) ↗